High tibial osteotomy (HTO) fixation can be achieved using various plate designs. Compared with nonlocking plates, the stability of locking plates allows patients to return to weight-bearing and work sooner and may also decrease postoperative complications, introducing the potential for overall cost savings. However, material costs for locking plates are higher, and the plate bulkiness may lead to additional surgery to remove the plate. We conducted a retrospective study to evaluate the cost-effectiveness of a locking versus a nonlocking plate in HTO from both the health care payer and societal perspectives up to 12 months postoperative. We observed that from a health care payer perspective, the locking plate was not cost-effective. However, the locking plate was cost-effective from the societal perspective (addition of indirect costs, such as time off work). These findings highlight the importance of considering costing perspective in economic evaluations for chronic conditions, particularly in publicly funded health care systems. 
Summary

DISCUSSIONS IN SURGERY
E15
To test this hypothesis, we retrospectively reviewed the cases of patients who underwent a medial opening wedge HTO with a locking plate versus a nonlocking plate and evaluated the cost-effectiveness from the health care payer (Ontario Ministry of Health and Long-Term Care) and societal perspectives at 12 months following surgery. A description of our methods and results are reported in Appendix 1, available at canjsurg.ca/018317-a1.
Our cost-effectiveness analysis showed that from the health care payer perspective, the use of a locking plate in HTO is unlikely to be cost-effective. The health care payer perspective includes any direct costs (e.g., surgery, staffing, imaging) to the public payer. However, from a societal perspective, the locking plate is highly likely to be cost-effective, highlighting the importance of costing perspective in economic evaluations. The societal perspective includes both direct and indirect costs (e.g., time off work).
Although patient-reported outcomes (Knee injury and Osteoarthritis Outcome Scores [KOOS]) slightly favoured the locking plate, the difference was not statistically significant, suggesting that the cost-effectiveness is highly driven by cost differences. We found that the surgical and postoperative complication costs were similar between groups. Therefore, the difference in direct cost between interventions (+$665 for the locking plate) is reflected in the difference in plate and screw costs.
The incremental cost-effectiveness ratio (ICER) value for the health care payer perspective was +$399.41 per 1 additional point improvement in the KOOS total change score, suggesting that the public payer must be willing to pay $4000 more per patient to achieve a clinically important improvement in KOOS (i.e., 10-point improvement) to use the locking plate. This was further supported by net benefit regression (NBR) and cost-effectiveness Fig. 1. (A) From the health care payer perspective, the probability that the locking plate is cost-effective did not exceed 55% at a willingness to pay (WTP) of $1000 or greater. (B) From the societal perspective, the locking plate was cost-effective with 99% certainty, regardless of WTP. acceptability curve (CEAC) results, which showed the probability that the locking plate is cost-effective does not exceed 55% at a willingness to pay (WTP) of $1000 (Fig. 1A) . Therefore, from a health care payer perspective, which looks strictly at direct costs to the public payer, the locking plate is likely not cost-effective. Alternatively, we found that by incorporating indirect costs (e.g., time off work) to evaluate from a societal perspective, the locking plate is cost-effective. The difference in societal costs between treatment groups favoured the locking plate, with $6228.21 cost savings at 12 months following HTO. Additionally, the NBR and CEAC indicated that the locking plate was cost-effective with 99% certainty, regardless of WTP (Fig. 1B) . The cost difference is largely attributable to a sooner return to work and activities for patients receiving the locking plate.
An institutional decision-maker examining our results may opt to use the nonlocking plate owing to lower system costs; however, considering solely the direct costs could substantially undermine the true societal benefit of using the locking plate. The rehabilitation period after HTO involves altered weight-bearing (i.e., crutch ambulation) that can continue several weeks after surgery. Consequently, most patients are required to take time off work and are limited in daily activities for extended periods of time, which can generate large losses in productivity for society, particularly for young patients (around 45 years of age) who are members of the working population. These are vital aspects to consider when assessing cost-effectiveness in this population.
In economic analyses for OA, much attention is given to the direct health care costs. Indeed, these costs are important to consider when comparing surgical interventions. However, this paper emphasizes that inclusion of indirect costs is arguably more important. An estimated 80% of the overall annual costs for OA result from time lost from work and leisure by both participants and unpaid caregivers. 2 In Canada, 1 in 8 workers has OA, and this number is projected to grow to 1 in 3 workers over the next few years.
1 Similar trends are seen in other chronic MSK conditions (e.g., rheumatoid arthritis) that lead to disability and for interventions, such as elective orthopedic interventions, that involve an extended recovery period that limits patient activity. As the rate of MSK diseases continues to increase along with its economic burden, it is essential to identify interventions that are cost-effective. Importantly, our results show that the conclusions regarding the value of interventions are likely to change depending on the perspective of the analysis. These findings highlight the importance for consideration of costing perspective in economic evaluations for chronic conditions, particularly in publicly funded health care systems.
